Literature DB >> 3460398

Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions.

H L Israel, P Karlin, H Menduke, O G DeLisser.   

Abstract

Chest roentgenograms of 152 patients with type 2/3 disease observed 3 or more years were reviewed using modified ILO/UC nomenclature. After a mean length of observation of 9.3 years, clinical recovery was observed in 71.7% and radiologic recovery in 48.0% of the patients. Age; duration of observation; mediastinal adenopathy; and character (xyz, pgr, stu), size, extent, and profusion of pulmonary densities were similar in the 53 white and 99 black patients, who differed significantly only in sex distribution. White patients achieved clinical recovery (84.9%) more often than black patients (64.7%) (p = .05). Factors influencing clinical recovery were analyzed by means of stepwise logistic linear regression. The initial roentgenographic features were unrelated to outcome; only race and extrathoracic disease proved to have significant predictive value. The probability of clinical recovery is estimated to be .894 in white patients with disease limited to the chest, .697 in white patients with extrathoracic disease, and .760 in black patients without and .454 in black patients with extrathoracic sarcoidosis. Recovery appears to be related not to the severity of the initial pulmonary reaction but to racially associated factors that influence extrathoracic dissemination as well as lung damage.

Entities:  

Mesh:

Year:  1986        PMID: 3460398     DOI: 10.1111/j.1749-6632.1986.tb18537.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Current concepts in the management of sarcoidosis.

Authors:  M M Muthiah; J T Macfarlane
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Mortality among African American women with sarcoidosis: data from the Black Women's Health Study.

Authors:  M H Tukey; J S Berman; D A Boggs; L F White; L Rosenberg; Y C Cozier
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-08-01       Impact factor: 0.670

3.  Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph.

Authors:  A Tazi; T Desfemmes-Baleyte; P Soler; D Valeyre; A J Hance; J P Battesti
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

Review 4.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

5.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

6.  Racial differences in sarcoidosis granuloma density.

Authors:  Robert R Burke; Chad H Stone; Suzanne Havstad; Benjamin A Rybicki
Journal:  Lung       Date:  2008-08-21       Impact factor: 2.584

7.  Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients.

Authors:  Gloria E Westney; Sadia Habib; Alexander Quarshie
Journal:  Lung       Date:  2007-03-24       Impact factor: 3.777

Review 8.  Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.

Authors:  Nisha A Gilotra; Jan M Griffin; Noelle Pavlovic; Brian A Houston; Jessica Chasler; Colleen Goetz; Jonathan Chrispin; Michelle Sharp; Edward K Kasper; Edward S Chen; Ron Blankstein; Leslie T Cooper; Emer Joyce; Farooq H Sheikh
Journal:  J Card Fail       Date:  2021-07-11       Impact factor: 5.712

9.  Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.

Authors:  Yusuke Inoue; Naoki Inui; Dai Hashimoto; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

10.  Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.

Authors:  Nicolas Belhomme; Stéphane Jouneau; Guillaume Bouzillé; Olivier Decaux; Mathieu Lederlin; Stéphanie Guillot; Antoinette Perlat; Patrick Jégo
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.